Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired⦠read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
$2.44
Price+5.48%
$0.13
$12.730m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$4.782m
-
1y CAGR-
3y CAGR-
5y CAGR-$42.115m
-
1y CAGR-
3y CAGR-
5y CAGR-$11.95
-
1y CAGR-
3y CAGR-
5y CAGR$10.408m
$28.114m
Assets$17.706m
Liabilities$11.687m
Debt41.6%
-0.3x
Debt to EBITDA-$35.972m
-
1y CAGR-
3y CAGR-
5y CAGR